Novartis settles with Lacks family over HeLa cell legacy
Novartis has reached a settlement with Henrietta Lacks' estate over the use of her HeLa cells in medical research, ending a dispute with undisclosed terms; the case highlights ongoing debates about consent and compensation tied to the iconic cell line used in biomedical advances since 1951.